Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation-Reference-Cited by-同舟云学术

Factors determining pbsc mobilization efficiency and nonmobilization following ICE with or without rituximab (R-ICE) salvage therapy for refractory or relapsed lymphoma prior to autologous transplantation

Published:2014-06-19 Issue:6 Volume:29 Page:322-330
ISSN:0733-2459
Container-title:Journal of Clinical Apheresis
language:en
Short-container-title:J. Clin. Apheresis

Author:

Xia Wei¹²³,Ma Chun Kei K⁴,Reid Cassandra¹,Bai Lijun¹²³,Wong Kelly¹,Kerridge Ian¹²,Ward Christopher¹²,Greenwood Matthew¹²

Affiliation:

1. Department of Haematology and Transfusion Medicine; Royal North Shore Hospital; Sydney Australia

2. Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney; Sydney Australia

3. Haematology Laboratory, PaLMs, Royal North Shore Hospital; Sydney Australia

4. Westmead Millennium Institute, University of Sydney; Sydney Australia

Publisher

Wiley

Subject

Hematology,General Medicine

Reference49 articles.

1. Harvesting of autologous blood stem cells after a mobilizing regimen with low-dose cyclophosphamide;Deliliers;Leuk Lymphoma,2002

2. Progenitor-cell mobilization after low-dose cyclophosphamide and granulocyte colony-stimulating factor: An analysis of quantity and quality and factors prediction for these parameters in 101 pretreated patients with malignant lymphoma;Watts;J Clin Oncol,1997

3. Predictors for optimal mobilization and subsequent engraftment of peripheral blood progenitor cells following intermediate dose cyclophosphamide and G-CSF;Morton;Leukemia Res,1997

4. Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors;Kotasek;Bone Marrow Transplant,1992

5. ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients;Akhtar;Bone Marrow Transplant,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plerixafor and granulocyte colony stimulating factor for poor mobilizers in patients undergoing autologous peripheral hematopoietic stem cell transplantation: Single institution study;Frontiers in Transplantation;2023-01-18

2. A retrospective study of autologous stem cell mobilization by G‑CSF in combination with chemotherapy in patients with multiple myeloma and lymphoma;Oncology Letters;2019-12-03

3. Peripheral Stem Cell Apheresis is Feasible Post 131Iodine-Metaiodobenzylguanidine-Therapy in High-Risk Neuroblastoma, but Results in Delayed Platelet Reconstitution;Clinical Cancer Research;2018-10-12

4. Mobilization of hematopoietic progenitor cells for autologous transportation: consensus recommendations;Revista da Associação Médica Brasileira;2016-10

5. Reappraising the timing of transplant for indolent non-Hodgkin lymphomas;Expert Review of Hematology;2016-08-31